The Tokyo-based company Oncolys BioPharma has developed the world's first oncology drug intended for the treatment of lung cancer, and its commercial sale may begin shortly.
Similar stories
Cooperation with Germany in the field of higher education will be expanded
Improving the quality of higher education, strengthening scientific research opportunities, and developing practical research remain one of the main directions in the country. Furthermore, shaping an innovative ecosystem and strengthening cooperation between universities and industry is also of great importance.
In addition, improving technology transfer mechanisms and introducing 'Industry 4.0' and smart manufacturing systems are also among the priority goals.
It is planned to expand cooperation relations with Germany in these areas.
Farrukh Rustamov's Doctoral Dissertation in Medical Sciences Defended
Farrukh Khalmuminovich Rustamov successfully defended his doctoral dissertation in medical sciences. The topic of his work was 'Improving the comprehensive treatment tactics for patients who have undergone tuberculous coxitis, based on the pathogenetic mechanisms of anatomical and functional disorders.'


